Cargando…

Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?

Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.

Detalles Bibliográficos
Autores principales: Ravishankar, Ramanish, Turkistani, Leenah, Elghoneimy, Yasser, Manoly, Imthiaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387662/
https://www.ncbi.nlm.nih.gov/pubmed/34471536
http://dx.doi.org/10.1002/ccr3.4085
_version_ 1783742488665653248
author Ravishankar, Ramanish
Turkistani, Leenah
Elghoneimy, Yasser
Manoly, Imthiaz
author_facet Ravishankar, Ramanish
Turkistani, Leenah
Elghoneimy, Yasser
Manoly, Imthiaz
author_sort Ravishankar, Ramanish
collection PubMed
description Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.
format Online
Article
Text
id pubmed-8387662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83876622021-08-31 Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era? Ravishankar, Ramanish Turkistani, Leenah Elghoneimy, Yasser Manoly, Imthiaz Clin Case Rep Case Report Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes. John Wiley and Sons Inc. 2021-03-29 /pmc/articles/PMC8387662/ /pubmed/34471536 http://dx.doi.org/10.1002/ccr3.4085 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ravishankar, Ramanish
Turkistani, Leenah
Elghoneimy, Yasser
Manoly, Imthiaz
Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
title Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
title_full Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
title_fullStr Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
title_full_unstemmed Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
title_short Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
title_sort aortic valve replacement in a patient with sickle cell disease—are we justified to perform surgery in the tavi era?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387662/
https://www.ncbi.nlm.nih.gov/pubmed/34471536
http://dx.doi.org/10.1002/ccr3.4085
work_keys_str_mv AT ravishankarramanish aorticvalvereplacementinapatientwithsicklecelldiseasearewejustifiedtoperformsurgeryinthetaviera
AT turkistanileenah aorticvalvereplacementinapatientwithsicklecelldiseasearewejustifiedtoperformsurgeryinthetaviera
AT elghoneimyyasser aorticvalvereplacementinapatientwithsicklecelldiseasearewejustifiedtoperformsurgeryinthetaviera
AT manolyimthiaz aorticvalvereplacementinapatientwithsicklecelldiseasearewejustifiedtoperformsurgeryinthetaviera